The DOI matches its Crossref record; 464 of the 476 references it cites were found in a registry or an index.
Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
Open accessAbstract
Much thought has been given to the impact of Amyloid Beta, Tau and Alpha-Synuclein in the development of Alzheimer's disease (AD) and Parkinson's disease (PD), yet the clinical failures of the recent decades indicate that there are further pathological mechanisms at work. Indeed, besides amyloids, AD and PD are characterized by the culminative interplay of oxidative stress, mitochondrial dysfunction and hyperfission, defective autophagy and mitophagy, systemic inflammation, BBB and vascular damage, demyelination, cerebral insulin resistance, the loss of dopamine production in PD, impaired neurogenesis and, of course, widespread axonal, synaptic and neuronal degeneration that leads to cognitive and motor impediments. Interestingly, the acylated form of the hormone ghrelin has shown the potential to ameliorate the latter pathologic changes, although some studies indicate a few complications that need to be considered in the long-term administration of the hormone. As such, this review will illustrate the wide-ranging neuroprotective properties of acylated ghrelin and critically evaluate the hormone's therapeutic benefits for the treatment of AD and PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, the beneficial role of ghrelin in the central nervous system has been widely discussed, including enhanced cognition [48, 59–61].”
From Protective PLCG2 variants associate with a delayed onset of Alzheimer’s disease among heterozygous APOE ε4 carriers (2026) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 464
AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration
Peixoto, C. A., Oliveira, W. H. D., Araújo, S. M. D. R., & Nunes, A. K. S. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.013 · Cited by 196 · cited 13×
“AG is also involved in the regulation of the adaptive immune system, which is based on the modulation of T-cells.”
BackgroundInfluentialSaresella, M., Calabrese, E., Marventano, I., Piancone, F., Gatti, A. V., Alberoni, M., Nemni, R., & Clerici, M. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.12.004 · Cited by 194
Ghrelin Down-regulates Proinflammatory Cytokines in Sepsis Through Activation of the Vagus Nerve
Wu, R., Dong, W., Cui, X., Zhou, M., Simms, H. H., Ravikumar, T. S., & Wang, P. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251614.42290.ed · Cited by 192
The Hypothalamic Mechanisms of the Hypophysiotropic Action of Ghrelin
Wren, A., Small, C. J., Fribbens, C. V., Neary, N. M., Ward, H. L., Seal, L., Ghatei, M. A., & Bloom, S. R. (2002) · Neuroendocrinology · doi:10.1159/000066629 · Cited by 191
KATUGAMPOLA, S. D., Pallikaros, Z., & Davenport, A. P. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704228 · Cited by 191 · cited 1×
“Although to a low degree, GHSR1α is also expressed throughout the cerebral vasculature and a markedly high density of GHS-R1α has been detected in the microvasculature of the granular layer of the cerebellum (Katugampola et al., 2001; Ku et al., 2015, 2016).”
BackgroundCataldo, A. M., Hamilton, D. J., & Nixon, R. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)91858-9 · Cited by 185
TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice
Zhao, C., Ling, Z., Newman, M. B., Bhatia, A., & Carvey, P. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.012 · Cited by 183 · cited 1×
“For example, the genetic deletion of TNF-α and the utility of the microglial inhibitor minocycline attenuated the MPTP-induced permeabilization of the BBB in this PD animal model (Zhao et al., 2007).”
Brain insulin resistance: role in neurodegenerative disease and potential for targeting
Hölscher, C. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1738383 · Cited by 180 · cited 3×
“…for AD and PD, it is no surprise that its early desensitization in the CNS, believed to predominantly occur in response to chronic inflammation, promotes the development of AD and PD (see Holscher, 2019 for further information) (Blazquez et al., 2014; Werner and LeRoith, 2014; Holscher, 2020).”
BackgroundSelf-citationInterleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer’s disease mice
Alves, S., Churlaud, G., Audrain, M., Michaelsen‐Preusse, K., Fol, R. R., Souchet, B., Braudeau, J., Körte, M., Klatzmann, D., & Cartier, N. (2016) · Brain · doi:10.1093/brain/aww330 · Cited by 178 · cited 1×
“For example, the long-term administration of low-doses of IL-2, believed to assist the activity of Tregs (Klatzmann and Abbas, 2015), enhanced the levels of Tregs in the rodent brain, improved the Aß42/40 ratio, stimulated the clearance of Aß plaques, elevated LTP, attenuated spinal degeneration and reversed memory im…”
BackgroundGSK‐3 in Neurodegenerative Diseases
Lei, P., Ayton, S., Bush, A. I., & Adlard, P. A. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/189246 · Cited by 177 · cited 1×
“In addition, insulin suppresses the activity of GSK-3ß, a wellknown Tau kinase (Lei et al., 2011), hence the loss of insulin signaling initiates Tau hyperphosphorylation and aggregation in AD (Hong and Lee, 1997; Schubert et al.”
BackgroundThe FoxO transcription factors and metabolic regulation
Nakae, J., Oki, M., & Cao, Y. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.025 · Cited by 176 · cited 16×
“As such, the function of variousmitochondrial master modulators, including AMPK and PGC1α, is disturbed in AD and PD.”
BackgroundInfluentialUCP2, a mitochondrial protein regulated at multiple levels
Donadelli, M., Dando, I., Fiorini, C., & Palmieri, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1407-0 · Cited by 175 · cited 1×
“Furthermore, AG promoted the mitochondrial biogenesis, resulting in increased numbers of nuclear respiratory factor (NRF)1-positive mitochondria (Jiang et al., 2008; Andrews et al., 2009a; Donadelli et al., 2014).”
BackgroundInflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts
Mamik, M. K., & Power, C. (2017) · Brain · doi:10.1093/brain/awx133 · Cited by 169 · cited 2×
“…has also recently been identified in AD and PD, believed to sequentially involve Aß accumulation, the Aß-triggered inflammasome activation, inflammasome-induced cytokine production and the onset of Tau pathology in AD (Mamik and Power, 2017; Ising et al., 2019; Stancu et al., 2019).”
BackgroundAltered lymphocyte distribution in Alzheimer’s disease
RICHARTZSALZBURGER, E., BATRA, A., STRANSKY, E., LASKE, C., KOHLER, N., BARTELS, M., BUCHKREMER, G., & SCHOTT, K. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.01.010 · Cited by 167 · cited 1×
“In accord with the animal studies, blood profiling of AD patients indicated heightened adaptive immune responses, such as a total reduction in naive T-cells, a tendency of T-cells to differentiate into CD4 subsets or the elevated activity of pro-inflammatory CD4 Th17 cells (Shalit et al., 1995; Richartz-Salzburger et…”
ResultLeung, P., Chow, K. B. S., Lau, P., Chu, K.-M., Chan, C., Cheng, C., & Wise, H. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.11.011 · Cited by 167 · cited 1×
“In contrast, a dominantnegative role for GHS-R1ß has been suggested, in which heterodimerization of GHS-R1ß with GHS-R1α encourages receptor endocytosis to obstruct intracellular signaling (Leung et al., 2007).”
BackgroundWerner, H., & LeRoith, D. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.020 · Cited by 167
Cannavino, J., Brocca, L., Sandri, M., Grassi, B., Bottinelli, R., & Pellegrino, M. A. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.286740 · Cited by 166
Anandhan, A., Jacome, M. S., Lei, S., Hernández-Franco, P., Pappa, A., Panayiotidis, M. I., Powers, R., & Franco, R. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.03.009 · Cited by 165
Fuel utilization by hypothalamic neurons: roles for ROS
Horváth, T. L., Andrews, Z. B., & Diano, S. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.10.003 · Cited by 165 · cited 29×
“The NTS, on the other hand, further projects across the entirety of the CNS, ultimately leading to the intestinal return of immune-suppressing signals through the afferent ends of the vagal nerve.”
InfluentialThe Growth Hormone Secretagogue Receptor: Its Intracellular Signaling and Regulation
Yin, Y., Li, Y., & Zhang, W. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034837 · Cited by 162 · cited 1×
“The induction of the cAMP/PKA pathway is highly debated and appears to be conditional and cell-type specific, however (Kohno et al., 2003; Yin et al., 2014; Yanagi et al., 2018).”
BackgroundWalker, A. K., Rivera, P. D., Wang, Q., Chuang, J.-C., Tran, S., Osborne-Lawrence, S., Estill, S. J., Starwalt, R., Huntington, P., Morlock, L., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.34 · Cited by 161 · cited 1×
“In concert, a study in depression-prone GHS-R1α mice revealed that the deletion of GHS-R1α exacerbated neuronal loss in response to chronic social defeat stress and diminished the proliferation of progenitor cells in the ventral DG (Walker et al., 2015).”
BackgroundThe Central Sirtuin 1/p53 Pathway Is Essential for the Orexigenic Action of Ghrelin
Velásquez, D. A., Martínez, G., Romero, A., Vázquez, M. J., Boit, K. D., Dopeso-Reyes, I. G., López, M., Vidal, A., Nogueiras, R., & Diéguez, C. (2011) · Diabetes · doi:10.2337/db10-0802 · Cited by 161 · cited 1×
“, 2016) as well as the hypothalamus in adult rodents and mouse models of aging (Velasquez et al., 2011; Fujitsuka et al., 2016).”
BackgroundBayliss, J. A., Lemus, M. B., Stark, R., dos Santos, V. V., Thompson, A., Rees, D. J., Galić, S., Elsworth, J. D., Kemp, B. E., Davies, J. S., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4373-15.2016 · Cited by 161 · cited 2×
“Mechanistically, AG is responsible for the neuroprotective effects of caloric reduction and stimulates AMPK activity in the SN of MPTP-treated rodents (Bayliss et al., 2016).”
BackgroundLysosomal recruitment of TSC2 is a universal response to cellular stress
Demetriades, C., Plescher, M., & Teleman, A. A. (2016) · Nature Communications · doi:10.1038/ncomms10662 · Cited by 160 · cited 1×
“autophagy and, typically in response to stressful cellular conditions and starvation, the activating phosphorylation of the cytoplasmic energy-sensor AMPK results in the AMPK-mediated phosphorylation of TSC1/2 and the inhibition of mTORC1 (Inoki et al., 2003;Manning andCantley, 2003; Demetriades et al., 2016).”
Borghammer, P., Chakravarty, M., Jonsdottir, K., Sato, N., Matsuda, H., Ito, K., Arahata, Y., Kato, T., & Gjedde, A. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0246-0 · Cited by 160 · cited 4×
“…of glucose that have been detected in the brains of AD (Lyingtunell et al., 1981, Eberling et al., 1992; Ogawa et al., 1996; Roher et al., 2012; de Eulate et al., 2017) and PD (Huang et al., 2008; Hosokai et al., 2009; Liepelt et al., 2009; Borghammer et al., 2010; Berti et al., 2012) patients.”
BackgroundInfluentialTargeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease
Curry, D. W., Stutz, B., Andrews, Z. B., & Elsworth, J. D. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-171296 · Cited by 160 · cited 1×
“The stimulation of AMPK, which is a highly debated therapeutic option for the treatment of PD, is, in fact, responsible for the large majority of AG’s neuroprotective effects, including (macro)autophagy, mitochondrial enhancement as well as the cellular safeguarding from oxidative stress and inflammation (Bayliss and…”
BackgroundIncreased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
Pisani, V., Stefani, A., Pierantozzi, M., Natoli, S., Stanzione, P., Franciotta, D., & Pisani, A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-188 · Cited by 158 · cited 1×
“Unsurprisingly, in line with the encouraged cerebral trespassing of lymphocytes, BBB leakage has been confirmed in the brains of PD patients (Kortekaas et al., 2005; Pisani et al., 2012).”
BackgroundWang, J., Song, Y., Zheng, C., & Leng, S. X. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1972714 · Cited by 158
Filichia, E., Hoffer, B. J., Qi, X., & Luo, Y. (2016) · Scientific Reports · doi:10.1038/srep32656 · Cited by 157 · cited 21×
“In the 1-methyl-4-phenyl-1,2,5,6 tetrahydropyridine (MPTP) mouse model of PD, AG protected from neuronal death in the SNpc, as displayed by the normalized B-cell lymphoma 2 (Bcl-2)/Bax ratio and lowered caspase-3 activity, stimulated the neuronal activity, elevated the production of multiple LCFAs, for instance palmit…”
BackgroundInfluentialObesity Impairs the Action of the Neuroendocrine Ghrelin System
Zigman, J. M., Bouret, S. G., & Andrews, Z. B. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.09.010 · Cited by 157 · cited 1×
“Based on the latest evidence, obesity and T2DM seem to encourage the development of ghrelin resistance (Zigman et al., 2016).”
BackgroundPeng, K.-G., Yang, L.-K., Wang, J., Ye, F., Dan, G., Zhao, Y.-P., Cai, Y., Cui, Z., Ao, L., Liu, J.-Y., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9944-9 · Cited by 155 · cited 1×
“To recharge NAD+ and FAD+ and to resume ATP generation, the brain relies on glucose as major energy substrate as well as its metabolization in the tricarboxylic acid cycle (TCA) as main bioenergetic pathway (Penicaud et al., 2002; Arun et al., 2016; Martinez-Reyes and Chandel, 2020).”
BackgroundBanks, W., Burney, B. O., & Robinson, S. (2008) · Peptides · doi:10.1016/j.peptides.2008.07.001 · Cited by 155 · cited 27×
“Indeed, besides amyloids, AD and PD are characterized by the culminative interplay of oxidative stress, mitochondrial dysfunction and hyperfission, defective autophagy and mitophagy, systemic inflammation, BBB and vascular damage, demyelination, cerebral insulin resistance, the loss of dopamine production in PD, impai…”
BackgroundInfluentialSIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy
Min, S., Sohn, P., Li, Y., Devidze, N., Johnson, J. R., Krogan, N. J., Masliah, E., Mok, S., Gestwicki, J. E., & Gan, L. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2369-17.2018 · Cited by 151 · cited 22×
“As such, this review will illustrate the wide-ranging neuroprotective properties of acylated ghrelin and critically evaluate the hormone’s therapeutic benefits for the treatment of AD and PD. Keywords: growth hormone secretagogue receptor 1 alpha, mitochondrial dysfunction, inflammation, autophagy, insulin resistance,…”
BackgroundInfluentialMoroo, I., Yamada, T., Makino, H., Tooyama, I., McGeer, P., Mcgeer, E., & Hirayama, K. (1994) · Acta Neuropathologica · doi:10.1007/bf00313602 · Cited by 149 · cited 1×
“Furthermore, components of the insulin pathway were found to be deactivated by inhibitory serine phosphorylation in the SN and basal ganglia, which appeared to precede dopamine neuron death, implying that the functional deterioration of insulin signaling manifests prematurely (Moroo et al., 1994; Takahashi et al., 199…”
BackgroundGhrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra
Jiang, H., Li, L.-J., Wang, J., & Xie, J.-X. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.006 · Cited by 144 · cited 4×
“Furthermore, AG promoted the mitochondrial biogenesis, resulting in increased numbers of nuclear respiratory factor (NRF)1-positive mitochondria (Jiang et al., 2008; Andrews et al., 2009a; Donadelli et al., 2014).”
BackgroundInfluentialGhrelin – Physiological Functions and Regulation
Abdalla, M. M. I. (2015) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2015.11.02.90 · Cited by 143 · cited 1×
“Other physiological processes that are commanded by ghrelin include the regulation of the gastrointestinal motility and acid secretion, cardiac function, osteoblast proliferation, bone maturation and muscular/myoblast outgrowth, the formation of long-term memory, the control of behaviors such as spontaneity, anxiety,…”
BackgroundIntersection of mTOR and STAT signaling in immunity
Saleiro, D., & Platanias, L. C. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.10.006 · Cited by 142
Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease
Tanji, K., Mori, F., Kakita, A., Takahashi, H., & Wakabayashi, K. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.022 · Cited by 141 · cited 1×
“There is also evidence that proteins involved in autophagosome initiation and formation, for example LC3 or ULK1/2, are sequestered into Lewy bodies in the brain of PD patients (Tanji et al., 2011; Miki et al., 2016).”
BackgroundMani, B. K., & Zigman, J. M. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.10.001 · Cited by 140 · cited 1×
“, 2008), which is in line with ghrelin’s physiological role as survival hormone (Mani and Zigman, 2017).”
BackgroundHippocampal dopamine/DRD1 signaling dependent on the ghrelin receptor
Kern, A., Mavrikaki, M., Ullrich, C., Albarran-Zeckler, R., Brantley, A. F., & Smith, R. G. (2015) · Cell · doi:10.1016/j.cell.2015.10.062 · Cited by 136
Moon, M., Choi, J. G., Nam, D. W., Hong, H., Choi, Y.-J., Oh, M. S., & Mook‐Jung, I. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101263 · Cited by 136 · cited 2×
“In such AD in vivo models, AG rescued from hippocampal atrophy, synaptic damage and the degeneration of cholinergic projections, heightened brain glycogen levels, diminished Aß aggregation and deposition, blocked Aβimparted deficits in LTPs, normalized plasticity-associated p-CREB levels, improved insulin sensitivity,…”
BackgroundKleinz, M. J., Maguire, J. J., Skepper, J. N., & Davenport, A. P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.09.001 · Cited by 135
Ghrelin‐induced adiposity is independent of orexigenic effects
Pérez–Tilve, D., Heppner, K. M., Kirchner, H., Lockie, S. H., Woods, S. C., Smiley, D. L., Tschöp, M. H., & Pfluger, P. T. (2011) · The FASEB Journal · doi:10.1096/fj.11-183632 · Cited by 134 · cited 1×
“In the periphery, for example, independent of the hormone’s orexigenic effects, AG stimulated the expression of lipogenic enzymes (fatty acid synthase (FAS), lipoprotein lipase and more) and lessened the transcription of carnitine palmitoyltransferase Ia (CPT1a), a ratelimiting effector necessary to induce fatty acid…”
BackgroundChao, Y.-X., He, B., & Tay, S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.09.003 · Cited by 133
Mitochondrial Transcription Factor A in the Maintenance of Mitochondrial DNA
Kang, D., & Hamasaki, N. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.010 · Cited by 132 · cited 1×
“Jointly, the PGC1α-induced transcriptional changes in mitochondria-associated genes protect from MPTP oxidative assault in cell and animal models of PD, whereas the deletion of PGC1α exacerbates MPTP-induced injury and excitotoxicity (Scarpulla, 2002, 2006; Kang and Hamasaki, 2005; St.-Pierre et al., 2006; Mudo et al.…”
BackgroundPerreault, M., Istrate, N., Wang, L., Nichols, A., Tozzo, E., & Stricker‐Krongrad, A. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802640 · Cited by 132 · cited 2×
“lowered plasma levels of AG and total ghrelin as well as decreased gastric synthesis of ghrelin and GOAT, yet also fail to secrete the hormone post-prandially and do not respond to the appetitestimulating effects of administered AG (Martin et al., 2004; Perreault et al., 2004; Briggs et al., 2010; Gardiner et al., 201…”
BackgroundHosokai, Y., Nishio, Y., Hirayama, K., Takeda, A., Ishioka, T., Sawada, Y., Suzuki, K., Itoyama, Y., Takahashi, S., Fukuda, H., et al. (2009) · Movement Disorders · doi:10.1002/mds.22444 · Cited by 132 · cited 5×
“…of glucose that have been detected in the brains of AD (Lyingtunell et al., 1981, Eberling et al., 1992; Ogawa et al., 1996; Roher et al., 2012; de Eulate et al., 2017) and PD (Huang et al., 2008; Hosokai et al., 2009; Liepelt et al., 2009; Borghammer et al., 2010; Berti et al., 2012) patients.”
BackgroundInfluentialJežek, P., Holendová, B., Garlid, K., & Jabůrek, M. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7225 · Cited by 131 · cited 1×
“As such, the induction of UCP2 buffers the glucose/TCA-exacerbated production of ROS by the ETC (see Jezek et al., 2018 for an extensive description of UCP functions), which may be protective in AD and PD. Similar to the SNpc (Andrews et al., 2009a), AG also augmented the induction of UCP2,…”
Frago, L. M., Pañeda, C., Dickson, S. L., Hewson, A. K., Argente, J., & Chowen, J. A. (2002) · Endocrinology · doi:10.1210/en.2002-220261 · Cited by 131 · cited 1×
“The injection of the ghrelin agonist GHRP-6 into healthy, adult rodents elevated the transcription levels of IGF1 in the hypothalamus, the cerebellum and the hippocampus, but not the cortex (Frago et al., 2002).”
BackgroundInsulin receptor mRNA in the substantia nigra in Parkinson's disease.
Takahashi, M., Yamada, T., Tooyama, I., Moroo, I., Kimura, H., Yamamoto, T., & Okada, H. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12357-0 · Cited by 131 · cited 1×
“Furthermore, components of the insulin pathway were found to be deactivated by inhibitory serine phosphorylation in the SN and basal ganglia, which appeared to precede dopamine neuron death, implying that the functional deterioration of insulin signaling manifests prematurely (Moroo et al., 1994; Takahashi et al., 199…”
BackgroundImpaired Hippocampal Neurogenesis and its Enhancement with Ghrelin in 5XFAD Mice
Moon, M., Cha, M.-Y., & Mook‐Jung, I. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132417 · Cited by 130 · cited 1×
“, 2018), and the 5xFAD animal model of AD (Moon et al., 2014).”
BackgroundThe Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review
Ambrosini, Y. M., Borcherding, D. C., Kanthasamy, A. G., Kim, H. J., Willette, A. A., Jergens, A. E., Allenspach, K., & Mochel, J. P. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00130 · Cited by 130 · cited 2×
“Moreover, intestinal inflammation and injury are strikingly pronounced prior to the onset of AD and PD, which, besides the additional inflammatory burden, induce the leakage of Aβ- and α-synuclein-like amyloids that may cross the enteric nervous system (ENS), enter the brain and stimulate cross-seeding (Ambrosini et a…”
BackgroundInnate and adaptive immune responses in neurodegeneration and repair
Amor, S., & Woodroofe, M. (2014) · Immunology · doi:10.1111/imm.12134 · Cited by 128
Quarta, D., Francesco, C. D., Melotto, S., Mangiarini, L., Heidbreder, C. A., & Hédou, G. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.006 · Cited by 127 · cited 1×
“When injected intracerebroventrically or intraVTA, AG further enhanced the locomotor activity of rodents (see Figure 3) (Abizaid et al., 2006; Jerlhag et al., 2007, 2012; Quarta et al., 2009; Skibicka et al., 2011, 2012; Cornejo et al., 2018).”
BackgroundGhrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats
Shimizu, Y., Nagaya, N., Teranishi, Y., Imazu, M., Yamamoto, H., Shokawa, T., Kangawa, K., Kohno, N., & Yoshizumi, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.085 · Cited by 126
Hewson, A. K., Tung, L. Y. C., Connell, D. W., Tookman, L. A., & Dickson, S. L. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3412 · Cited by 125 · cited 2×
“Since leptin functions as a physiological and anorexic counteragent to ghrelin in the hypothalamus, blocking intraneuronal AG/GHS-R1α-signaling, some studies have suggested that the elevated plasma pools of leptin during obesity weaken the sensitivity toward AG (Hewson et al., 2002; Kohno et al., 2007; Briggs et al.,…”
BackgroundTLR4 Polymorphisms and Ageing: Implications for the Pathophysiology of Age-Related Diseases
Balistreri, C. R., Colonna‐Romano, G., Lio, D., Candore, G., & Caruso, C. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9297-5 · Cited by 125 · cited 2×
“In this context, some genetic variants of TLR4 have been linked to AD and the increased expression of TLR2 has been identified in AD models (Balistreri et al., 2009; Letiembre et al., 2009), whereas the enhanced transcription of TLR2 and TLR4 have been detected in α-synuclein and MPTP mouse models of PD (Panaro et al.”
BackgroundSatou, M., Nishi, Y., Yoh, J., Hattori, Y., & Sugimoto, H. (2010) · Endocrinology · doi:10.1210/en.2010-0412 · Cited by 125
Lage, R., Vázquez, M. J., Varela, L., Saha, A. K., Vidal‐Puig, A., Nogueiras, R., Diéguez, C., & López, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-150672 · Cited by 123 · cited 3×
“AG was shown to induce the synthesis of FoxO1 in the hypothalamus (Lage et al., 2010) and, under conditions of cellular stress, FoxO1 drives the transcription of various anti-oxidant enzymes, such as the PGC1α-co-activated, mitochondrialMnSOD (St.”
BackgroundMitochondrial Biology and Neurological Diseases
Arun, S., Liu, L., & Dönmez, G. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150703154541 · Cited by 123
Hornsby, A. K. E., Redhead, Y. T., Rees, D. J., Ratcliff, M., Reichenbach, A., Wells, T., Francis, L. W., Amstalden, K. A. Z., Andrews, Z. B., & Davies, J. S. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.09.023 · Cited by 123 · cited 4×
“Various studies have testified that the administration of AG boosts adult hippocampal neurogenesis in healthy rodents (Zhao et al., 2014; Kent et al., 2015; Hornsby et al., 2016), dwarf rats (Li et al.”
BackgroundInfluentialLymphocyte subset patterns and cytokine production in Alzheimer's disease patients
Speciale, L., Calabrese, E., Saresella, M., Tinelli, C., Mariani, C., Sanvito, L., Longhi, R., & Ferrante, P. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.020 · Cited by 122
Marleau, S., Harb, D. E., Bujold, K., Avallone, R., Iken, K., Wang, Y., Demers, A., Sirois, M. G., Febbraio, M., Silverstein, R. L., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3253fje · Cited by 122 · cited 2×
“Moreover, the prolonged daily injection of the CD36-favoring ghrelin derivate EP 80317 dramatically ameliorated the development of vascular lesions in the apoE animal model of arteriosclerosis by lessening the CD36-driven endocytosis of oxidized low density lipoprotein (oxLDL) by macrophages (Marleau et al., 2005).”
BackgroundKohno, D., Nakata, M., Maekawa, F., Fujiwara, K., Maejima, Y., Kuramochi, M., Shimazaki, T., Okano, H., Onaka, T., & Yada, T. (2007) · Endocrinology · doi:10.1210/en.2006-1240 · Cited by 122 · cited 1×
“…a physiological and anorexic counteragent to ghrelin in the hypothalamus, blocking intraneuronal AG/GHS-R1α-signaling, some studies have suggested that the elevated plasma pools of leptin during obesity weaken the sensitivity toward AG (Hewson et al., 2002; Kohno et al., 2007; Briggs et al., 2014).”
BackgroundGhrelin Regulates Hippocampal Neurogenesis in Adult Mice
Moon, M., Kim, S., Hwang, L., & Seungjoon, P. A. R. K. (2009) · Endocrine Journal · doi:10.1507/endocrj.k09e-089 · Cited by 122
Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer’s Disease
Hölscher, C. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00088 · Cited by 122 · cited 8×
“…the driving factor in the maturation of insulin resistance during obesity, T2DM and neurodegenerative diseases, including AD and PD (Tateya et al., 2013; Holscher, 2019), it is implied that AG enhances insulin sensitivity by suppressing systemic inflammation, hyperlipidemia and oxidative assault.”
BackgroundInfluentialSelf-citationGhrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus.
Lee, J., Lim, E., Kim, Y., Li, E., & Park, S. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0040 · Cited by 119
Carlini, V., Martini, A., Schiöth, H., Ruiz, R., de Cuneo, M. F., & Debarioglio, S. R. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.015 · Cited by 119
Huang, J., Liu, W., Doycheva, D. M., Gamdzyk, M., Lu, W., Tang, J., & Zhang, J. H. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.07.001 · Cited by 118 · cited 2×
“Considerably, AG stimulates the activity of the fusion/fissionregulators AMPK and PGC-1α in GHS-R1α-expressing cells, including neurons (Bayliss and Andrews, 2013; Huang et al., 2019).”
BackgroundDiet-induced obesity causes peripheral and central ghrelin resistance by promoting inflammation
Naznin, F., Toshinai, K., Waise, T. M. Z., NamKoong, C., Moin, A. S. M., Sakoda, H., & Nakazato, M. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0139 · Cited by 118 · cited 3×
“In particular, the vagal nodose ganglion has been shown to desensitize, exhibiting the reduced expression of GHS-R1α, diminished AMPK activation and reduced electric current flow upon exposure to AG (Naznin et al., 2015).”
BackgroundRoles of Neuropeptide Y in Neurodegenerative and Neuroimmune Diseases
Li, C.-R., Wu, X.-J., Liu, S., Zhao, Y., Zhu, J., & Liu, K.-D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00869 · Cited by 117
mTOR Signaling in Parkinson’s Disease
Lan, A., Chen, J., Zhao, Y., Chai, Z., & Hu, Y. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8417-7 · Cited by 117 · cited 3×
“, 2020), also considering that autophagy is initiated by the inactivation of mTOR (Lan et al., 2017).”
BackgroundZhou, H.-L., Lin, R.-B., He, C., Zhang, Y.-B., Feng, N.-D., Wang, Q., Deng, F., Zhang, J.-P., & Chen, X.-M. (2013) · Nature Communications · doi:10.1038/ncomms3534 · Cited by 116
Fujitsuka, N., Asakawa, A., Morinaga, A., Amitani, M. S., Amitani, H., Katsuura, G., Sawada, Y., Sudo, Y., Uezono, Y., Mochiki, E., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.220 · Cited by 114 · cited 18×
“Furthermore, AMPK phosphorylates glyceraldehyde 3- phosphate dehydrogenase (GAPDH) at Ser122 during starvation to encourage the nuclear trafficking of GAPDH and the displacement of SIRT1 from its repressor Deleted in Breast Cancer 1 (DBC1) (Chang et al., 2015).”
BackgroundInfluentialKurkowska-Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-1999-1289 · Cited by 114 · cited 1×
“Further in vivo studies in the MPTP model support the idea that, in conjunction with BBB injury and the loss of tight junction proteins in the nigrostriatal area, the pathological infiltration of lymphocytes and other immune cells as well as the T-cell-driven induction of microglia occur in the SN (Kurkowska-Jastrzebs…”
ResultRole of matrix metalloproteinase-3 in neurodegeneration
Kim, E., & Hwang, O. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07082.x · Cited by 114
Concomitant Release of Ventral Tegmental Acetylcholine and Accumbal Dopamine by Ghrelin in Rats
Jerlhag, E., Janson, A. C., Waters, N., & Engel, J. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049557 · Cited by 114
Minogue, A. M., Jones, R. S., Kelly, R. J., McDonald, C., Connor, T. J., & Lynch, M. A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.026 · Cited by 112 · cited 1×
“Additionally, altered adaptive immune mechanics have been observed in the CNS of several Aß-based in vivo models of AD, displaying hippocampal BBB disruption, the infiltration of peripheral monocytes/macrophages, neutrophils and CD4 T-cells (predominantly Th1 and Th17) as well as the increased transcription of pro-inf…”
BackgroundSignaling through the ghrelin receptor modulates hippocampal function and meal anticipation in mice
Davis, J. F., Choi, D. L., Clegg, D., & Benoit, S. (2010) · Physiology and Behavior · doi:10.1016/j.physbeh.2010.10.017 · Cited by 110 · cited 1×
“On the other hand, the genetic deletion of ghrelin or knockdown of GHS-R1α lessened the numbers of hippocampal synapses, worsened LTP and impaired long-term memory (Diano et al., 2006; Davis et al., 2011), although discrepancies between spatial and contextual memory have been reported in GHS-R1α-null mice (AlbarranZec…”
BackgroundDemers, A., Mcnicoll, N., Febbraio, M., Servant, M., Marleau, S., Silverstein, R., & Ong, H. (2004) · Biochemical Journal · doi:10.1042/bj20040036 · Cited by 110 · cited 11×
“This receptor has been reported to act as an inflammatory conductor for Aß, leading to the production of ROS and proinflammatory cytokines upon the interaction of fibrillar Aß with microglial or macrophage CD36 (Coraci et al., 2002; Bamberger et al., 2003; El Khoury et al., 2003; Demers et al., 2004).”
BackgroundInfluentialConti, B., Sugama, S., Lucero, J. D., Winsky‐Sommerer, R., Wirz, S. A., Maher, P. A., Andrews, Z. B., Barr, A. M., Morale, M. C., Pañeda, C., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03052.x · Cited by 107 · cited 1×
“Of note, mutational studies in UCP2-modified and MPTPtreated mice revealed that UCP2 is a joint key mediator in the protection of SN-VTA dopaminergic neurons from apoptosis, the decrease of ROS as well as the increase of mitochondrial biogenesis (Andrews et al., 2005; Conti et al., 2005).”
BackgroundInsulin and norepinephrine regulate ghrelin secretion from a rat primary stomach cell culture.
Gagnon, J., & Anini, Y. (2012) · Endocrinology · doi:10.1210/en.2012-1040 · Cited by 106 · cited 1×
“Conversely, increased circulatory levels of glucose and long-chain fatty acids (LCFA) following meal intake as well as the postprandial release of insulin block the secretion of ghrelin (Gagnon and Anini, 2012; Lu et al., 2012; Sakata et al., 2012).”
BackgroundVestergaard, E., Hansen, T. K., Gormsen, L., Jakobsen, P., Møller, N., Christiansen, J., & Jørgensen, J. (2007) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00682.2006 · Cited by 106 · cited 1×
“However, clinical studies in healthy, non-obese subjects have shown that the infusion of AG impairs the glucose-stimulated secretion of insulin, diminishes glucose tolerance and worsens insulin sensitivity (Gauna et al., 2004; Vestergaard et al., 2007; Tong et al., 2010, 2014).”
BackgroundImproved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice.
Longo, K., Charoenthongtrakul, S., Giuliana, D. J., Govek, E., McDonagh, T., Qi, Y., Distefano, P., & Geddes, B. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.03.011 · Cited by 105 · cited 1×
“Furthermore, GHS-R1α antagonists, GOAT inhibitors and the genetic deletion of GHS-R1α enhanced the release of insulin, glucose tolerance, insulin sensitivity and weight loss in in vivo models of obesity (Sun et al., 2006; Esler et al., 2007; Longo et al., 2008; Barnett et al., 2010; Qi et al., 2011).”
BackgroundDepboylu, C., Stricker, S., Ghobril, J.-P., Oertel, W. H., Priller, J., & Höglinger, G. U. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.020 · Cited by 104 · cited 1×
“Further in vivo studies in the MPTP model support the idea that, in conjunction with BBB injury and the loss of tight junction proteins in the nigrostriatal area, the pathological infiltration of lymphocytes and other immune cells as well as the T-cell-driven induction of microglia occur in the SN (Kurkowska-Jastrzebs…”
ResultPeptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels
Shi, L., Bian, X., Qu, Z., Ma, Z., Zhou, Y., Wang, K., Jiang, H., & Xie, J. (2013) · Nature Communications · doi:10.1038/ncomms2439 · Cited by 103 · cited 1×
“In an extensive study, it was demonstrated that AG binds to nigral neurons, triggers neuronal firing and enhances dopamine turnover, achieving an impressive three-fold increase in total dopamine levels in the striatum of healthy mice (Shi et al., 2013).”
Background(2021) · Encyclopedia of Molecular Pharmacology · doi:10.1007/978-3-030-57401-7_300502 · Cited by 103 · cited 28×
“Indeed, besides amyloids, AD and PD are characterized by the culminative interplay of oxidative stress, mitochondrial dysfunction and hyperfission, defective autophagy and mitophagy, systemic inflammation, BBB and vascular damage, demyelination, cerebral insulin resistance, the loss of dopamine production in PD, impai…”
BackgroundInfluentialLee, J. Y., Choi, H. Y., Ahn, H., Ju, B. G., & Yune, T. Y. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.07.016 · Cited by 103
Dixit, V., Yang, H., Cooper-Jenkins, A., Giri, B., Patel, K., & Taub, D. (2009) · Blood · doi:10.1182/blood-2008-09-181255 · Cited by 102 · cited 15×
“, 2004) and its synthesis by T-cells declined with age, whereas the infusion of AG reversed the age-correlating increase in a large number of pro-inflammatory cytokines and chemokines in old rats (Dixit et al., 2009).”
BackgroundMethodInfluentialBrain glucose sensing mechanism and glucose homeostasis
Pénicaud, L., Leloup, C., Lorsignol, A., Alquier, T., & Guillod, E. (2002) · Current opinion in clinical nutrition and metabolic care · doi:10.1097/00075197-200209000-00013 · Cited by 101 · cited 1×
“To recharge NAD and FAD and to resume ATP generation, the brain relies on glucose as major energy substrate as well as its metabolization in the tricarboxylic acid cycle (TCA) as main bioenergetic pathway (Penicaud et al., 2002; Arun et al., 2016; Martinez-Reyes and Chandel, 2020).”
BackgroundGhrelin’s Relationship to Blood Glucose
Mani, B. K., Shankar, K., & Zigman, J. M. (2019) · Endocrinology · doi:10.1210/en.2019-00074 · Cited by 101 · cited 1×
“As a major metabolic hormone, AG elevates the secretion of growth hormone (GH) by the pituitary gland, reduces insulin, yet increases glucagon secretion by pancreatic cells and promotes the hepatic release of glucose into the blood, thus maintaining steady plasma glucose levels during fasting (Mani et al., 2019).”
BackgroundGhrelin: ghrelin as a regulatory Peptide in growth hormone secretion.
Khatib, N., Gaidhane, S., Gaidhane, A., Khatib, M., Simkhada, P., Gode, D., & Zahiruddin, Q. (2014) · Journal of clinical and diagnostic research : JCDR · doi:10.7860/jcdr/2014/9863.4767 · Cited by 100
Lu, X.-P., Zhao, X.-L., Feng, J., Liou, A., Anthony, S., Pechhold, S., Sun, Y.-X., Lu, H.-Y., & Wank, S. (2012) · American Journal of Physiology - Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00541.2011 · Cited by 100 · cited 1×
“Conversely, increased circulatory levels of glucose and long-chain fatty acids (LCFA) following meal intake as well as the postprandial release of insulin block the secretion of ghrelin (Gagnon and Anini, 2012; Lu et al., 2012; Sakata et al., 2012).”
BackgroundGahete, M., Rubio, A., Córdoba-Chacón, J., Gracia-Navarro, F., Kineman, R., Ávila, J., Luque, R., & Castaño, J. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100873 · Cited by 100 · cited 4×
“Considering the vast neuroprotective properties of AG, it is likely that the insufficient availability of ghrelin and the reduced ghrelin sensitivity in the CNS, such as the temporal lobe (Gahete et al., 2010), contribute to age-related cognitive decline.”
BackgroundInfluentialFunctional implications of limited leptin receptor and ghrelin receptor coexpression in the brain
Perelló, M., Scott, M. M., Sakata, I., Lee, C. E., Chuang, J.-C., Osborne-Lawrence, S. L., Rovinsky, S. A., Elmquist, J. K., & Zigman, J. M. (2011) · The Journal of Comparative Neurology · doi:10.1002/cne.22690 · Cited by 99 · cited 29×
“The NTS, on the other hand, further projects across the entirety of the CNS, ultimately leading to the intestinal return of immune-suppressing signals through the afferent ends of the vagal nerve.”
BackgroundInfluentialGlucose-mediated control of ghrelin release from primary cultures of gastric mucosal cells
Sakata, I., Park, W.-M., Walker, A. K., Piper, P. K., Chuang, J.-C., Osborne-Lawrence, S. L., & Zigman, J. M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00041.2012 · Cited by 98
The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders
Costales, J. L., & Kolevzon, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.01.001 · Cited by 98
Unger, M. M., Möller, J. C., Mankel, K., Eggert, K. M., Bohne, K., Bodden, M., Stiasny-Kolster, K., Kann, P. H., Mayer, G., Tebbe, J. J., et al. (2011) · Journal of Neurology · doi:10.1007/s00415-010-5864-1 · Cited by 97 · cited 1×
“, 2012), the basal plasma levels of ghrelin and the postprandial secretion of the hormone were diminished in PD patients (Fiszer et al., 2010; Unger et al., 2011).”
BackgroundCheyuo, C., Wu, R., Zhou, M., Jacob, A., Coppa, G. F., & Wang, P. (2010) · Shock · doi:10.1097/shk.0b013e3181f48a37 · Cited by 97
Altered energy metabolism in Alzheimer's disease.
Ogawa, M., Fukuyama, H., Ouchi, Y., Yamauchi, H., & Kimura, J. (1996) · Journal of Neurological Sciences · doi:10.1016/0022-510x(96)00033-0 · Cited by 97 · cited 4×
“Moreover, by increasing blood flow, AG might ameliorate the pathologically diminished cerebral blood flow and deficits in the CNS delivery of glucose that have been detected in the brains of AD (Lyingtunell et al., 1981, Eberling et al., 1992; Ogawa et al., 1996; Roher et al., 2012; de Eulate et al., 2017) and PD (Hua…”
BackgroundInfluentialT lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease.
Shalit, F., Sredni, B., Brodie, C., Kott, E., & Huberman, M. (1995) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1995.1078 · Cited by 97
Tong, M., Dong, M., & de la Monte, S. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0995 · Cited by 95 · cited 1×
“Furthermore, components of the insulin pathway were found to be deactivated by inhibitory serine phosphorylation in the SN and basal ganglia, which appeared to precede dopamine neuron death, implying that the functional deterioration of insulin signaling manifests prematurely (Moroo et al., 1994; Takahashi et al., 199…”
BackgroundChung, Y. C., Kim, Y.-S., Bok, E., Yune, T. Y., Maeng, S., & Jin, B. K. (2013) · Mediators of Inflammation · doi:10.1155/2013/370526 · Cited by 94 · cited 1×
“MMP-3 is also implicated in BBB damage in PD (Chung et al., 2013) and activates MMP-9 (Lee et al.”
BackgroundKent, B. A., Beynon, A. L., Hornsby, A. K. E., Bekinschtein, P., Bussey, T. J., Davies, J. S., & Saksida, L. M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.015 · Cited by 94 · cited 2×
“Various studies have testified that the administration of AG boosts adult hippocampal neurogenesis in healthy rodents (Zhao et al., 2014; Kent et al., 2015; Hornsby et al., 2016), dwarf rats (Li et al.”
BackgroundReduced temporal lobe blood flow in alzheimer's disease
Eberling, J. L., Jagust, W., Reed, B., & Baker, M. G. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90076-a · Cited by 93
Erşahin, M., Toklu, H., Erzik, C., Çetinel, Ş., Akakın, D., Velioğlu-Öğünç, A., Tetik, Ş., Özdemir, Z. N., Şener, G., & Yeg̃en, B. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1210 · Cited by 93 · cited 3×
“Moreover, AG downregulated the transcription of IL-1 and/or the inflammasome-activating cytokine TNF-α in face of MPTPinjury (PD), threohydroxyaspartate (THA)/kainic acid-assault (excitotoxicity), subarachnoid hemorrhage and SCI (Moon et al., 2009a; Ersahin et al., 2010; Lee J. et al., 2010; Lee et al., 2012, 2014b; A…”
BackgroundWu, R., Dong, W., Ji, Y., Zhou, M., Marini, C. P., Ravikumar, T. S., & Wang, P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002026 · Cited by 92
Ghrelin Regulates Glucose and Glutamate Transporters in Hypothalamic Astrocytes
Fuente-Martín, E., García-Cáceres, C., Argente-Arizón, P., Díaz, F., Granado, M., Freire-Regatillo, A., Castro-González, D., Ceballos, M. L., Frago, L. M., Dickson, S. L., et al. (2016) · Scientific Reports · doi:10.1038/srep23673 · Cited by 91 · cited 1×
“Ultimately, the latter changes led to reduced glucose uptake, elevated glutamate uptake and the steadily rising lactate levels in the cell culture medium (Fuente-Martin et al., 2016).”
BackgroundInhibition of Apoptotic Cell Death by Ghrelin Improves Functional Recovery after Spinal Cord Injury
Lee, J. Y., Chung, H., Yoo, Y. S., Oh, Y. J., Oh, T. H., Park, S., & Yune, T. Y. (2010) · Endocrinology · doi:10.1210/en.2009-1416 · Cited by 91
The role of cytochrome c oxidase deficient hippocampal neurones in Alzheimer's disease
Cottrell, D., Borthwick, G., Johnson, M., Ince, P. G., & Turnbull, D. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00414.x · Cited by 91 · cited 1×
“Generally, functional deficits in complex 1 are associated with PD and defects in complex IV are implicated in AD (Cottrell et al., 2002; Arun et al., 2016).”
BackgroundAdult Conditional Knockout of PGC-1α Leads to Loss of Dopamine Neurons
Jiang, H.-S., Kang, S.-U., Zhang, S.-R., Karuppagounder, S. S., Xu, J.-C., Lee, Y.-K., Kang, B.-G., Lee, Y., Zhang, J., Pletnikova, O., et al. (2016) · eNeuro · doi:10.1523/eneuro.0183-16.2016 · Cited by 90 · cited 1×
“The promitochondrial impact of PGC1α in PD, whose expression levels were found to be decreased in the brains of PD patients, has been made evident in knockdown studies, in which the suppression or conditional knockdown of PGC1α led to the selective atrophy of dopaminergic neurons in the SNpc and lessened dopamine pool…”
BackgroundLeptin and ghrelin concentrations and weight loss in Parkinson’s disease
Fiszer, U., Michalowska, M., Baranowska, B., Wolińska‐Witort, E., Jeske, W., Jethon, M., Piaścik-Gromada, M., & Marcinowska-Suchowierska, E. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01185.x · Cited by 90 · cited 1×
“, 2012), the basal plasma levels of ghrelin and the postprandial secretion of the hormone were diminished in PD patients (Fiszer et al., 2010; Unger et al., 2011).”
BackgroundMicroglia activation due to obesity programs metabolic failure leading to type two diabetes
Maldonado‐Ruiz, R., Montalvo-Martínez, L., Fuentes‐Mera, L., & Camacho‐Morales, A. (2017) · Nutrition and Diabetes · doi:10.1038/nutd.2017.10 · Cited by 87 · cited 1×
“On the other hand, it is plausible that the initial, inflammationdriven desensitization of insulin and other growth factors during obesity, T2DM, AD and PD (Maldonado-Ruiz et al., 2017; Holscher, 2019, 2020), which negatively affect the rate of cellular protein translation though the loss of Akt/mTORC1-signaling (Hols…”
BackgroundBansal, V., Ryu, S. Y., Lopez, N., Allexan, S. S., Krzyżaniak, M., Eliceiri, B. P., Baird, A., & Coimbra, R. S. M. (2011) · Inflammation · doi:10.1007/s10753-011-9307-7 · Cited by 87
Insulin resistance and gray matter volume in neurodegenerative disease
Morris, J. K., Vidoni, E. D., Perea, R. D., Rada, R. C., Johnson, D. K., Lyons, K. E., Pahwa, R., Burns, J. M., & Honea, R. A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.006 · Cited by 87 · cited 2×
“…deactivated by inhibitory serine phosphorylation in the SN and basal ganglia, which appeared to precede dopamine neuron death, implying that the functional deterioration of insulin signaling manifests prematurely (Moroo et al., 1994; Takahashi et al., 1996; Tong et al., 2009; Morris et al., 2014).”
BackgroundGhrelin is neuroprotective in Parkinson’s disease: molecular mechanisms of metabolic neuroprotection
Bayliss, J. A., & Andrews, Z. B. (2013) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018813479645 · Cited by 86 · cited 33×
“Moreover, a recent study revealed a cytoprotective function of AG in palmitate- and glucose-stressed human microvascular endothelial cells, in which AG rescued apoptosis and caspase-3 activity by inhibiting the stress kinases p38 and JNK1/2, diminishing the mitochondrial generation of ROS and normalizing the rate of o…”
BackgroundInfluentialCognitive enhancing effects of ghrelin receptor agonists
Atcha, Z., Chen, W.-S., Ong, A., Wong, F.-K., Neo, A., Browne, E. R., Witherington, J., & Pemberton, D. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1620-6 · Cited by 84
Ghrelin: A link between ageing, metabolism and neurodegenerative disorders
Stoyanova, I. I. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.026 · Cited by 84 · cited 1×
“It has been proposed that the PD-related Lewy body pathology in the myenteric plexus of the stomach and in the DMV, which innervates the gut and navigates the gastrointestinal motility, might impair the release of ghrelin (Stoyanova, 2014).”
BackgroundGLP-1 receptor agonists show neuroprotective effects in animal models of diabetes
Gault, V. A., & Hölscher, C. (2018) · Peptides · doi:10.1016/j.peptides.2017.11.017 · Cited by 83 · cited 2×
““Perhaps there is a field of treasures right there, waiting to be discovered” (Gault and Holscher, 2018).”
BackgroundSelf-citationDual destructive and protective roles of adaptive immunity in neurodegenerative disorders
Anderson, K. M., Olson, K. E., Estes, K. A., Flanagan, K., Gendelman, H. E., & Mosley, R. L. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-25 · Cited by 83
Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats*
Wu, R., Dong, W., Qiang, X., Wang, H., Blau, S. A., Ravikumar, T. S., & Wang, P. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a557a2 · Cited by 81
The Pharmacokinetics of Acyl, Desacyl and Total Ghrelin in Healthy Human Subjects
Tong, J., Dave, N., Mugundu, G., Davis, H., Gaylinn, B., Thorner, M., Tschöp, M., D'Alessio, D., & Desai, P. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0072 · Cited by 81 · cited 1×
“4 h, respectively, have been reported for AG in human plasma and∼27min in rat serum, whereas the degradation t1/2 of total circulatory ghrelin has been estimated to be as short as ∼9-11min (De Vriese et al., 2004; Liu et al., 2008; Tong et al., 2013).”
BackgroundIwakura, H., Hosoda, K., Son, C., Fujikura, J., Tomita, T., Noguchi, M., Ariyasu, H., Takaya, K., Masuzaki, H., Ogawa, Y., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411358200 · Cited by 81 · cited 1×
“Likewise, chronically increased plasma ghrelin levels did not lead to any complications in adult rodents, although it might promote hyperglycemia with age (Iwakura et al., 2005; Reed et al., 2008).”
BackgroundDhurandhar, E. J., Allison, D. B., van Groen, T., & Kadish, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060437 · Cited by 79 · cited 2×
“In such AD in vivo models, AG rescued from hippocampal atrophy, synaptic damage and the degeneration of cholinergic projections, heightened brain glycogen levels, diminished Aß aggregation and deposition, blocked Aβimparted deficits in LTPs, normalized plasticity-associated p-CREB levels, improved insulin sensitivity,…”
BackgroundBulgarelli, I., Tamiazzo, L., Bresciani, E., Rapetti, D., Caporali, S., Lattuada, D., Locatelli, V., & Torsello, A. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22088 · Cited by 78 · cited 3×
“, 2002), it is likely that the binding of DAG sterically hinders the proinflammatory interaction of CD36 with Aß (Bulgarelli et al., 2009).”
BackgroundAvallone, R., Demers, A., Rodrigue-Way, A., Bujold, K., Harb, D. E., Anghel, S., Wahli, W., Marleau, S., Ong, H., & Tremblay, A. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0146 · Cited by 77 · cited 1×
“Hexarelin was demonstrated to interact with both GHS-R1α and CD36 on cultured THP-1 monocytes and primary peritoneal macrophages derived from apoE mice (Avallone et al., 2006).”
BackgroundKatayama, M., Nogami, H., Nishiyama, J., Kawase, T., & Kawamura, K. (2000) · Neuroendocrinology · doi:10.1159/000054602 · Cited by 77 · cited 1×
“The decreased sensitivity toward AG could be related to an age-induced decline in the transcriptional levels of GHS-R1α, as reported for the anterior pituitary in 24-month-old Lou C/Jall rats, the vagal nerve in aged Fischer-344 rats and the brainstem in rats and dwarf rats (Katayama et al., 2000; Kappeler et al., 200…”
AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia
Ruozi, G., Bortolotti, F., Falcione, A., Ferro, M. D., Ukovich, L., Macedo, A., Zentilin, L., Filigheddu, N., Cappellari, G. G., Baldini, G., et al. (2015) · Nature Communications · doi:10.1038/ncomms8388 · Cited by 77
Insulin resistance, neuroinflammation, and Alzheimer’s disease
Najem, D., Bamji‐Mirza, M., Chang, N., Liu, Q. Y., & Zhang, W. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0050 · Cited by 76 · cited 1×
“Over time, prolonged neuroinflammation encourages various other secondary complications, such as impairments in protein degradation, amyloid misfolding, Tau hyperphosphorylation (in conjunction with the inflammationperpetuating activation of the inflammasome), permeabilization of the BBB, peripheral immune cell infilt…”
BackgroundMenges, S., Minakaki, G., Schaefer, P. M., Meixner, H., Prots, I., Schlötzer-Schrehardt, U., Friedland, K., Winner, B., Outeiro, T., Winklhofer, K., et al. (2017) · Scientific Reports · doi:10.1038/srep42942 · Cited by 74 · cited 1×
“, 2014), it must be noted that wt α-synuclein, in fact, promotes fusion and its expression may be a compensatory and protective mechanism to prevent hyperfission in PD (Berthet et al., 2014; Guardia-Laguarta et al., 2014; Menges et al., 2017).”
BackgroundFerreira‐Marques, M., Aveleira, C. A., Carmo‐Silva, S., Botelho, M., de Almeida, L. P., & Cavadas, C. (2016) · Aging · doi:10.18632/aging.100996 · Cited by 74 · cited 2×
“In contrast, the limited amount of cerebral studies with AG, at the very least, have verified the induction of autophagy via mTOR inhibition in cortical neurons (Ferreira-Marques et al., 2016).”
BackgroundGhrelin and Neurodegenerative Disorders—a Review
Shi, L.-M., Du, X.-X., Jiang, H., & Xie, J.-X. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9729-1 · Cited by 73
Briggs, D. I., Lockie, S., Benzler, J., Wu, Q., Stark, R., Reichenbach, A., Hoy, A., Lemus, M., Coleman, H., Parkington, H., et al. (2014) · Endocrinology · doi:10.1210/en.2013-1861 · Cited by 72 · cited 1×
“Since leptin functions as a physiological and anorexic counteragent to ghrelin in the hypothalamus, blocking intraneuronal AG/GHS-R1α-signaling, some studies have suggested that the elevated plasma pools of leptin during obesity weaken the sensitivity toward AG (Hewson et al., 2002; Kohno et al., 2007; Briggs et al.,…”
BackgroundThe Role of Ghrelin in Regulating Synaptic Function and Plasticity of Feeding-Associated Circuits
Serrenho, D., Santos, S. D., & Carvalho, A. L. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00205 · Cited by 69
Suppression of Experimental Autoimmune Encephalomyelitis by Ghrelin1
Theil, M., Miyake, S., Mizuno, M., Tomi, C., Croxford, J., Hosoda, H., Theil, J., von Hörsten, S., Yokote, H., Chiba, A., et al. (2009) · Journal of Immunology · doi:10.4049/jimmunol.0803362 · Cited by 68 · cited 1×
“Immune cell invasion into the spinal cord was only blocked by AG in some of these studies, however, which might have been related to the choice of the EAE-initiating antigen used for immunization (Theil et al., 2009; Souza-Moreira et al., 2013; Liu F. et al., 2019).”
BackgroundThe dorsal motor nucleus of the vagus and regulation of pancreatic secretory function
Mussa, B. M., & Verberne, A. J. M. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2012.066472 · Cited by 68 · cited 1×
“In concert, the area postrema, the nucleus tractus solitarius and the dorsal motor nucleus of the vagus (DMV) form the dorsal vagal complex (DVC) that serves as a commanding platform for the autonomic nervous system, navigating gastrointestinal motility, secretory activity and pancreatic hormone release (Price et al.,…”
BackgroundIglesias, M. A., Furler, S. M., Cooney, G. J., Kraegen, E. W., & Ye, J. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1649 · Cited by 67 · cited 15×
“Furthermore, AMPK phosphorylates glyceraldehyde 3- phosphate dehydrogenase (GAPDH) at Ser122 during starvation to encourage the nuclear trafficking of GAPDH and the displacement of SIRT1 from its repressor Deleted in Breast Cancer 1 (DBC1) (Chang et al., 2015).”
BackgroundInfluentialGhrelin administration enhances neurogenesis but impairs spatial learning and memory in adult mice
Zhao, Z., Liu, H., Xiao, K., Yu, M., Cui, L., Zhu, Q., Zhao, R., Li, G.-D., & Zhou, Y. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.063 · Cited by 67 · cited 1×
“Various studies have testified that the administration of AG boosts adult hippocampal neurogenesis in healthy rodents (Zhao et al., 2014; Kent et al., 2015; Hornsby et al., 2016), dwarf rats (Li et al.”
BackgroundTong, X., Wu, D., Wang, X., Chen, H., Chen, J.-X., Wang, X.-X., Wang, X.-L., Gan, L., Guo, Z.-Y., Shi, G.-X., et al. (2012) · Peptides · doi:10.1016/j.peptides.2012.06.020 · Cited by 67 · cited 2×
“, 2010) and, under conditions of cellular stress, FoxO1 drives the transcription of various anti-oxidant enzymes, such as the PGC1α-co-activated, mitochondrialMnSOD (St.-Pierre et al., 2006; Hsu et al., 2010; Tong et al., 2012).”
BackgroundCilostazol Activates AMP-activated Protein Kinase and Restores Endothelial Function in Diabetes
Suzuki, K., Uchida, K., Nakanishi, N., & Hattori, Y. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.6 · Cited by 66 · cited 1×
“, 2013) and the stimulation of AMPK was proven to trigger the AMPKconveyed activating phosphorylation of eNOS at Ser1177 in cultured human and rat endothelial cells, thus strengthening vasodilation in vivo (Morrow et al., 2003; Suzuki et al., 2008), it is highly likely that the AG-evoked liberation of NO is”
BackgroundSantos, V. V. D., Stark, R., Rial, D., Silva, H. B. L., Bayliss, J., Lemus, M. B., Davies, J. S., Cunha, R. A., Prediger, R. D., & Andrews, Z. B. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12476 · Cited by 66
Panaro, M. A., Lofrumento, D. D., Saponaro, C., Nuccio, F. D., Cianciulli, A., Mitolo, V., & Nicolardi, G. (2008) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970802278557 · Cited by 65 · cited 1×
“, 2009), whereas the enhanced transcription of TLR2 and TLR4 have been detected in α-synuclein and MPTP mouse models of PD (Panaro et al., 2008; Letiembre et al., 2009), indicating that immune regulation is harmfully altered in AD and PD.”
BackgroundLiu, F., Li, Z.-J., He, X., Yu, H.-Y., & Feng, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01320 · Cited by 65
Kodama, T., Ashitani, J., Matsumoto, N., Kangawa, K., & Nakazato, M. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.05.001 · Cited by 65
Ezquerro, S., Méndez-Giménez, L., Becerril, S., Moncada, R., Valentí, V., Catalán, V., Gómez‐Ambrosi, J., Frühbeck, G., & Rodrı́guez, A. (2016) · Scientific Reports · doi:10.1038/srep39942 · Cited by 64 · cited 1×
“AG-evoked autophagy ismainly connected to the downstream activation of the phospho-AMPK/mTOR axis, as it has been welldescribed for the initiation of autophagy in peripheral tissue (Tong et al., 2012; Mao et al., 2015; Ruozi et al., 2015; Ezquerro et al., 2016; Xu et al., 2017).”
BackgroundAlbarran-Zeckler, R. G., Brantley, A. F., & Smith, R. G. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.012 · Cited by 64
Ghrelin Antagonized 1-Methyl-4-Phenylpyridinium (MPP+)-Induced Apoptosis in MES23.5 Cells
Dong, J., Song, N., Xie, J.-X., & Jiang, H. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9162-7 · Cited by 64 · cited 3×
“5 dopaminergic cells (Dong et al., 2009; Yu et al., 2016), rotenone-burdened rat retinal ganglion cells (Liu et al., 2018) and primary hypothalamic neurons during oxygen and glucose withdrawal (Chung et al., 2007).”
BackgroundTNF-Α May Mediate Inflammasome Activation in the Absence of Bacterial Infection in More than One Way
Álvarez, S., & Muñoz‐Fernández, M. Á. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071477 · Cited by 63
Cornejo, M. P., Barrile, F., Francesco, P. N. D., Portiansky, E. L., Reynaldo, M., & Perelló, M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.09.027 · Cited by 63 · cited 1×
“When injected intracerebroventrically or intraVTA, AG further enhanced the locomotor activity of rodents (see Figure 3) (Abizaid et al., 2006; Jerlhag et al., 2007, 2012; Quarta et al., 2009; Skibicka et al., 2011, 2012; Cornejo et al., 2018).”
BackgroundPTEN regulates cilia through Dishevelled
Shnitsar, I., Bashkurov, M., Masson, G., Ogunjimi, A., Mosessian, S., Cabeza, E., Hirsch, C. L., Trcka, D., Gish, G., Jiao, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9388 · Cited by 62
Karasawa, H., Pietra, C., Giuliano, C., García-Rubio, S., Xu, X., Yakabi, S., Taché, Y., & Wang, L.-X. (2014) · Neurogastroenterology and Motility · doi:10.1111/nmo.12459 · Cited by 62 · cited 2×
“…the combinatorial administration of the ghrelin agonist HM01 or AG with the dopamine-replacing drugs Ldopa or L-dopa/levodopa prevented the L-dopa- and 6-OHDAassociated slowing of the gastric motility and constipation in the 6-OHDA rodent model of PD (Wang et al., 2012; Karasawa et al., 2014).”
BackgroundEslami, M., Sadeghi, B., & Goshadrou, F. (2018) · Hippocampus · doi:10.1002/hipo.23002 · Cited by 62 · cited 1×
“In such AD in vivo models, AG rescued from hippocampal atrophy, synaptic damage and the degeneration of cholinergic projections, heightened brain glycogen levels, diminished Aß aggregation and deposition, blocked Aβimparted deficits in LTPs, normalized plasticity-associated p-CREB levels, improved insulin sensitivity,…”
BackgroundPure human butyrylcholinesterase hydrolyzes octanoyl ghrelin to desacyl ghrelin.
Schopfer, L., Lockridge, O., & Brimijoin, S. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.05.017 · Cited by 61
Martin, N. M., Small, C., Sajedi, A., Patterson, M., Ghatei, M. A., & Bloom, S. R. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802646 · Cited by 61 · cited 1×
“lowered plasma levels of AG and total ghrelin as well as decreased gastric synthesis of ghrelin and GOAT, yet also fail to secrete the hormone post-prandially and do not respond to the appetitestimulating effects of administered AG (Martin et al., 2004; Perreault et al., 2004; Briggs et al., 2010; Gardiner et al., 201…”
BackgroundDate, Y. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-381272-8.00016-7 · Cited by 61 · cited 1×
“The binding of plasma AG to GHS-R1α on the afferent vagal ends mutes vagal firing, contributing to the initiation of feeding and GHrelease (Date, 2012).”
BackgroundLying-tunell, U., Lindblad, B., Malmlund, H., & Persson, B. (1981) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1981.tb00788.x · Cited by 60 · cited 2×
“In accord with insulin resistance, glucose hypometabolism in the CNS, for instance within the cortex, has been linked to the transition from MCI to AD and cognitive dysfunction (Lyingtunell et al., 1981; Hoyer et al., 1988; Ogawa et al., 1996; Drzezga et al., 2003; Mosconi et al., 2008).”
BackgroundGhrelin Prevents Disruption of the Blood–Brain Barrier after Traumatic Brain Injury
Lopez, N., Krzyżaniak, M., Blow, C., Putnam, J., Ortiz-Pomales, Y. T., Hageny, A., Eliceiri, B. P., Coimbra, R. S. M., & Bansal, V. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.2053 · Cited by 59 · cited 2×
“Thus, by diminishing total inflammation, the secretion of pro-inflammatory DAMPs and inflammation-driven BBB injury, AG was capable of preventing neutrophil infiltration into the CNS (Ersahin et al., 2010, 2011; Lopez et al., 2012a,b, Mohaddes et al., 2017).”
BackgroundNeuroprotective Actions of Ghrelin and Growth Hormone Secretagogues
Frago, L., Baquedano, E., Argente, J., & Chowen, J. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00023 · Cited by 59 · cited 10×
“Interestingly, AG equally appears to elevate the synthesis of IGF-1 in some brain regions.”
InfluentialGhrelin improves vascular autophagy in rats with vascular calcification
Xu, M.-M., Liu, L., Song, C.-F., Chen, W., & Gui, S.-Y. (2017) · Life Science · doi:10.1016/j.lfs.2016.11.025 · Cited by 58
Diet-induced obesity causes ghrelin resistance in reward processing tasks
Lockie, S. H., Dinan, T., Lawrence, A. J., Spencer, S. J., & Andrews, Z. B. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.08.004 · Cited by 58
Gomes, S., Martins, I., Fonseca, A. C., Oliveira, C. R., Resende, R., & Pereira, C. (2014) · Journal of neuroendocrinology · doi:10.1111/jne.12138 · Cited by 57 · cited 6×
“In the brains of these AD-like mice, AG further suppressed glycogen synthase kinase 3β (GSK-3β) activity and Tau hyperphosphorylation (Kang et al., 2015).”
BackgroundInfluentialGhrelin inhibits LPS-induced release of IL-6 from mouse dopaminergic neurones
Beynon, A. L., Brown, M. R., Wright, R., Rees, M., Sheldon, I., & Davies, J. S. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-40 · Cited by 56 · cited 15×
“Furthermore, in vitro studies have shown that the administration of AG downregulated the synthesis of IL-1β, IL-6, and TNFα in human peripheral blood mononuclear cells following irritation with the mitogen phytohemagglutinin (Dixit et al., 2004).”
BackgroundResultInfluentialGhrelin and leptin secretion in patients with moderate Alzheimer's disease
Theodoropoulou, A., Metallinos, I. C., Psyrogiannis, A., Vagenakis, G., & Kyriazopoulou, V. (2012) · The Journal of Nutrition, Health & Aging · doi:10.1007/s12603-012-0058-4 · Cited by 56 · cited 1×
“While no relevant alterations in the blood levels of ghrelin have been observed in AD patients (Proto et al., 2006; Theodoropoulou et al., 2012), the basal plasma levels of ghrelin and the postprandial secretion of the hormone were diminished in PD patients (Fiszer et al.”
BackgroundThe Hormone Ghrelin Prevents Traumatic Brain Injury Induced Intestinal Dysfunction
Bansal, V., Ryu, S., Blow, C., Costantini, T., Loomis, W., Eliceiri, B., Baird, A., Wolf, P., & Coimbra, R. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1372 · Cited by 56 · cited 1×
“, 2011), inflammation-driven intestinal permeabilization and atrophy (Wu et al., 2008, 2009a; Bansal et al., 2010).”
BackgroundCharacterization of the insulin sensitivity of ghrelin receptor KO mice using glycemic clamps
Qi, Y., Longo, K. A., Giuliana, D. J., Gagne, S., McDonagh, T., Govek, E. K., Nolan, A. L., Zou, C., Morgan, K., Hixon, J., et al. (2011) · BMC Physiology · doi:10.1186/1472-6793-11-1 · Cited by 56 · cited 1×
“Furthermore, GHS-R1α antagonists, GOAT inhibitors and the genetic deletion of GHS-R1α enhanced the release of insulin, glucose tolerance, insulin sensitivity and weight loss in in vivo models of obesity (Sun et al., 2006; Esler et al., 2007; Longo et al., 2008; Barnett et al., 2010; Qi et al., 2011).”
BackgroundGhrelin-Mediated Hippocampal Neurogenesis: Implications for Health and Disease
Buntwal, L., Sassi, M., Morgan, A. H., Andrews, Z. B., & Davies, J. S. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.07.001 · Cited by 55
Mir, M., Tolosa, L., Asensio, V. J., Lladó, J., & Olmos, G. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.07.002 · Cited by 55 · cited 1×
“, 2009), and serum-derived or locally released TNFα and IFN-γ, whose combinatorial action was shown to be a crucial inflammatory mediator of dopaminergic cell death in a rodent model of PD (Mir et al., 2008; Barcia et al., 2011).”
BackgroundGoebel-Stengel, M., Hofmann, T., Elbelt, U., Teuffel, P., Ahnis, A., Kobelt, P., Lambrecht, N., Klapp, B., & Stengel, A. (2013) · Peptides · doi:10.1016/j.peptides.2013.02.011 · Cited by 55 · cited 1×
“Notably, the presence of GOAT has been detected in human serum, the hippocampus and the temporal gyrus (Gahete et al., 2010; Goebel-Stengel et al., 2013; Murtuza and Isokawa, 2018).”
BackgroundLiepelt, I., Reimold, M., Maetzler, W., Godau, J., Reischl, G., Gaenslen, A., Herbst, H., & Berg, D. (2009) · Movement Disorders · doi:10.1002/mds.22662 · Cited by 55 · cited 2×
“Interestingly, various studies have indicated that PD patients also exhibit cortical glucose hypometabolism and diminished blood flow in this area (Huang et al., 2008; Hosokai et al., 2009; Liepelt et al., 2009; Borghammer et al., 2010; Berti et al., 2012), a decreased rate of glucose consumption in the frontal lobe a…”
BackgroundLeptin and ghrelin prevent hippocampal dysfunction induced by Aβ oligomers
Martins, I., Gomes, S. R. A. M., Costa, R. O., Otvos, L., Oliveira, C. R., Resende, R., & Pereira, C. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.062 · Cited by 54 · cited 6×
“In the brains of these AD-like mice, AG further suppressed glycogen synthase kinase 3β (GSK-3β) activity and Tau hyperphosphorylation (Kang et al., 2015).”
BackgroundInfluentialKhraiwesh, H. M., Lopez-Dominguez, J. A., López‐Lluch, G., Navas, P., de Cabo, R., Ramsey, J. J., Villalba, J. M., & González-Reyes, J. A. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt006 · Cited by 54
Lee, J., Choi, H., Na, W. H., Ju, B., & Yune, T. (2014) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2014.09.006 · Cited by 53
Author Correction: mTOR at the nexus of nutrition, growth, ageing and disease
Liu, G. Y., & Sabatini, D. (2020) · Nature reviews. Molecular cell biology · doi:10.1038/s41580-020-0219-y · Cited by 51 · cited 2×
“, 2017; Holscher, 2019, 2020), which negatively affect the rate of cellular protein translation though the loss of Akt/mTORC1-signaling (Holscher, 2019; Liu and Sabatini, 2020), might be responsible for the reduced cerebral expression of GHS-R1α and GOAT in the cortex, hypothalamus and, potentially, further brain regi…”
BackgroundAnti-inflammatory Effect of Obestatin and Ghrelin in Dextran Sulfate Sodium–Induced Colitis in Rats
Pamukcu, O., Kumral, Z. N. Ö., Ercan, F., Yeg̃en, B., & Ertem, D. (2013) · Journal of Pediatric Gastroenterology and Nutrition - JPGN · doi:10.1097/mpg.0b013e318294711e · Cited by 51 · cited 1×
“For instance, the administration of AG succeeded in the animal model of colitis, showing downregulated local and systemic release of pro-inflammatory modulators, reduced inflammatory Th 1 activity, elevated action of immunosuppressive regulatory T-cells (Tregs), diminished oxidative stress, ameliorated intestinal tiss…”
BackgroundEndogenous ghrelin-O-acyltransferase (GOAT) acylates local ghrelin in the hippocampus
Murtuza, M., & Isokawa, M. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14244 · Cited by 50 · cited 2×
“Notably, the presence of GOAT has been detected in human serum, the hippocampus and the temporal gyrus (Gahete et al., 2010; Goebel-Stengel et al., 2013; Murtuza and Isokawa, 2018).”
BackgroundDiminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer’s Disease Mice
Bartolotti, N., Segura, L., & Lazarov, O. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150650 · Cited by 50 · cited 1×
“In such AD in vivo models, AG rescued from hippocampal atrophy, synaptic damage and the degeneration of cholinergic projections, heightened brain glycogen levels, diminished Aß aggregation and deposition, blocked Aβimparted deficits in LTPs, normalized plasticity-associated p-CREB levels, improved insulin sensitivity,…”
BackgroundTong, J., Davis, H., Summer, S., Benoit, S., Haque, A., Bidlingmaier, M., Tschöp, M., & D'Alessio, D. (2014) · Diabetes · doi:10.2337/db13-1598 · Cited by 50 · cited 1×
“However, clinical studies in healthy, non-obese subjects have shown that the infusion of AG impairs the glucose-stimulated secretion of insulin, diminishes glucose tolerance and worsens insulin sensitivity (Gauna et al., 2004; Vestergaard et al., 2007; Tong et al., 2010, 2014).”
BackgroundMiki, Y., Tanji, K., Mori, F., Utsumi, J., Sasaki, H., Kakita, A., Takahashi, H., & Wakabayashi, K. (2015) · Brain Pathology · doi:10.1111/bpa.12297 · Cited by 50 · cited 1×
“There is also evidence that proteins involved in autophagosome initiation and formation, for example LC3 or ULK1/2, are sequestered into Lewy bodies in the brain of PD patients (Tanji et al., 2011; Miki et al., 2016).”
BackgroundDaulatzai, M. A. (2012) · Neurochemical Research · doi:10.1007/s11064-011-0680-2 · Cited by 49 · cited 1×
“It has been proposed that chronic inflammation provokes NTS dysfunction, which, in turn, propagates neuroinflammation and death across the brain in AD (Daulatzai, 2012; Wang J. T. et al., 2018).”
BackgroundJeong, Y.-O., Shin, S. J., Park, J., Ku, B., Song, J.-S., Kim, J.-J., Jeon, S., Lee, S. M., & Moon, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061800 · Cited by 48 · cited 4×
“In such AD in vivo models, AG rescued from hippocampal atrophy, synaptic damage and the degeneration of cholinergic projections, heightened brain glycogen levels, diminished Aß aggregation and deposition, blocked Aβimparted deficits in LTPs, normalized plasticity-associated p-CREB levels, improved insulin sensitivity,…”
BackgroundInfluentialThe role of ghrelin in GH secretion and GH disorders
Nass, R., Gaylinn, B., & Thorner, M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.03.021 · Cited by 48 · cited 1×
“In the periphery, AG has been deemed as the most powerful stimulator of the GH/IGF-1 axis (Nass et al., 2011).”
BackgroundKiewiet, R. M., van Aken, M. V., van der Weerd, K., Uitterlinden, P., Themmen, A., Hofland, L., de Rijke, Y. D., Delhanty, P., Ghigo, E., Abribat, T., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0339 · Cited by 48
Reduced Cerebral Blood Flow in Mild Cognitive Impairment Assessed Using Phase-Contrast MRI
de Eulate, R. G., Goñi, I., Galiano, A., Vidorreta, M., Recio, M., Riverol, M., Zubieta, J. L., & Fernández-Seara, M. A. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161222 · Cited by 48
Lopez, N. E., Gastón, L., López, K., Coimbra, R., Hageny, A.-M., Putnam, J. G., Eliceiri, B., Coimbra, R., & Bansal, V. (2012) · Brain Research · doi:10.1016/j.brainres.2012.10.031 · Cited by 47 · cited 2×
“Thus, by diminishing total inflammation, the secretion of pro-inflammatory DAMPs and inflammation-driven BBB injury, AG was capable of preventing neutrophil infiltration into the CNS (Ersahin et al., 2010, 2011; Lopez et al., 2012a,b, Mohaddes et al., 2017).”
BackgroundKunath, N., van Groen, T., Allison, D. B., Kumar, A., Dozier-Sharpe, M., & Kadish, I. (2015) · Scientific Reports · doi:10.1038/srep11452 · Cited by 47 · cited 3×
“In such AD in vivo models, AG rescued from hippocampal atrophy, synaptic damage and the degeneration of cholinergic projections, heightened brain glycogen levels, diminished Aß aggregation and deposition, blocked Aβimparted deficits in LTPs, normalized plasticity-associated p-CREB levels, improved insulin sensitivity,…”
BackgroundMice with chronically increased circulating ghrelin develop age-related glucose intolerance.
Reed, J. A., Benoit, S., Pfluger, P., Tschöp, M., D'Alessio, D., & Seeley, R. (2008) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00463.2007 · Cited by 46 · cited 1×
“Likewise, chronically increased plasma ghrelin levels did not lead to any complications in adult rodents, although it might promote hyperglycemia with age (Iwakura et al., 2005; Reed et al., 2008).”
BackgroundFujimura, K., Wakino, S., Minakuchi, H., Hasegawa, K., Hosoya, K., Komatsu, M., Kaneko, Y., Shinozuka, K., Washida, N., Kanda, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094373 · Cited by 46 · cited 2×
“The activation of SIRT1 via AG has been confirmed in the periphery (Fujimura et al., 2014; Tamaki et al., 2015; Fujitsuka et al., 2016; Yang et al., 2016) as well as the hypothalamus in adult rodents and mouse models of aging (Velasquez et al.”
BackgroundSirago, G., Conte, E., Fracasso, F., Cormio, A., Fehrentz, J., Martínez, J., Musicco, C., Camerino, G., Fonzino, A., Rizzi, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13504-y · Cited by 45 · cited 2×
“This is in line with the Mfn2-upregulating and Drp1-impeding function of PGC-1α (Peng et al., 2017), suggesting that AG stimulates the AMPK/PGC-1α axis to ameliorate mitochondrial fragmentation in response to cellular stress (Sirago et al., 2017).”
BackgroundWan, S.-X., Shi, B., Lou, X., Liu, J.-Q., Ma, G.-G., Liang, D.-Y., & Ma, S. (2016) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2016.08.048 · Cited by 45
The neurotoxic effect of astrocytes activated with toll-like receptor ligands
Ma, D., Jin, S., Li, E., Doi, Y., Parajuli, B., Noda, M., Sonobe, Y., Mizuno, T., & Suzumura, A. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.08.010 · Cited by 44 · cited 17×
“Moreover, AG downregulated the transcription of IL-1 and/or the inflammasome-activating cytokine TNF-α in face of MPTPinjury (PD), threohydroxyaspartate (THA)/kainic acid-assault (excitotoxicity), subarachnoid hemorrhage and SCI (Moon et al., 2009a; Ersahin et al., 2010; Lee J. et al., 2010; Lee et al., 2012, 2014b; A…”
BackgroundInfluentialBarazzoni, R., Semolic, A., Cattin, M. R., Zanetti, M., & Guarnieri, G. (2013) · Obesity · doi:10.1002/oby.20454 · Cited by 44
The hyperphagic effect of ghrelin is inhibited in mice by a diet high in fat.
Gardiner, J., Campbell, D., Patterson, M., Kent, A., Ghatei, M., Bloom, S., & Bewick, G. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.012 · Cited by 44 · cited 1×
“lowered plasma levels of AG and total ghrelin as well as decreased gastric synthesis of ghrelin and GOAT, yet also fail to secrete the hormone post-prandially and do not respond to the appetitestimulating effects of administered AG (Martin et al., 2004; Perreault et al., 2004; Briggs et al., 2010; Gardiner et al., 201…”
BackgroundLiu, L., Xu, H.-M., Jiang, H., Wang, J., Song, N., & Xie, J.-X. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.11.009 · Cited by 44 · cited 14×
“AG is also involved in the regulation of the adaptive immune system, which is based on the modulation of T-cells.”
MethodInfluentialGhrelin Inhibits the Differentiation of T Helper 17 Cells through mTOR/STAT3 Signaling Pathway
Xu, Y., Li, Z.-R., Yin, Y., Lan, H., Wang, J., Zhao, J., Feng, J., Li, Y., & Zhang, W.-Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117081 · Cited by 43
Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration
Cortés, N., Andrade, V., Guzmán‐Martínez, L., Estrella, M., & Maccioni, R. B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040956 · Cited by 43 · cited 1×
“Furthermore, pathogen-associated molecular patterns (PAMPs) that originate from cerebral infections, such as LPS, or, in the case of AD, infections with members of the Herpesviridae family and Hepatitis C virus, may further potentiate neuroinflammation (Morales et al., 2014; Sochocka et al., 2017; Cortes et al., 2018;…”
BackgroundVirdis, A., Duranti, E., Colucci, R., Ippolito, C., Tirotta, E., Lorenzini, G., Bernardini, N., Blandizzi, C., & Taddei, S. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv365 · Cited by 42 · cited 1×
“Additionally, clinical studies indicate that AG, in an endothelial nitic oxide synthase (eNOS)-mediated and GH-independent manner, enhances the bioavailability of NO and elicits vasorelaxation, hence improving blood flow and decreasing blood pressure (Nagaya et al., 2001, 2004; Shimizu et al., 2003; Tesauro et al., 20…”
BackgroundKang, S.-N., Moon, N., Kim, D. S., Kim, S. H., & Park, S. (2015) · Peptides · doi:10.1016/j.peptides.2015.07.005 · Cited by 41 · cited 3×
“In such AD in vivo models, AG rescued from hippocampal atrophy, synaptic damage and the degeneration of cholinergic projections, heightened brain glycogen levels, diminished Aß aggregation and deposition, blocked Aβimparted deficits in LTPs, normalized plasticity-associated p-CREB levels, improved insulin sensitivity,…”
BackgroundLee, S., Kim, Y., Li, E., & Park, S. (2012) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2012.16.1.43 · Cited by 41 · cited 1×
“, 2014b, 2015), as well as drug-induced excitotoxicity (Lee J. et al., 2010; Lee et al., 2012).”
BackgroundGao, S., Casals, N., Keung, W., Moran, T. H., & Lopaschuk, G. D. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.03.030 · Cited by 40 · cited 1×
“Moreover, under physiological conditions, AG was shown to discourage, rather than elevate, fatty acid oxidation in the hypothalamic ARC and in the cortex (Lage et al., 2010; Gao et al., 2013; Mir et al., 2018).”
BackgroundMyelin injury in the central nervous system and Alzheimer's disease.
Wang, S.-S., Zhang, Z., Zhu, T., Chu, S.-F., He, W.-B., & Chen, N.-H. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.05.003 · Cited by 40
Flagged first, then by citations
12 of the 476 references couldn’t be matched to a known paper.
Research works printed but not linked: 7
- Jerlhag, 2010, Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference, Psychopharmacology, 211, 415, 10.1007/s00213-010-1907-7 · DOI
- Konturek, 2009, Ghrelin ameliorates colonic inflammation. role of nitric oxide and sensory nerves, J. Physiol. Pharmacol, 60, 41
- Majumder, 2011, Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits, PLoS ONE, 6, e25416, 10.1371/journal.pone.0025416 · DOI · Paper page
- Mao, 2015, Ghrelin attenuated lipotoxicity via autophagy induction and nuclear factor-kappa B inhibition, Cell. Physiol. Biochem., 37, 563, 10.1159/000430377 · DOI
- Poewe, 2017, Parkinson disease, Nat. Rev. Dis., 3, 17013, 10.1038/nrdp.2017.13 · DOI · Paper page
- Yokochi, 2007, Mesolimbic and mesocortical pathways in parkinson disease, Brain Nerve 59, 943, 10.11477/mf.1416100129 · DOI
- Zhang, 2008, Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity, Cell, 135, 61, 10.1016/j.cell.2008.07.043 · DOI · Paper page
Cited by
Sorted by citations
Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248
Self-citationAcetyl-CoA Metabolism and Histone Acetylation in the Regulation of Aging and Lifespan
Bradshaw, P. C. (2021) · Antioxidants · doi:10.3390/antiox10040572 · Cited by 189
“Ghrelin has shown efficacy for the treatment of several mouse models of neurodegenerative disease consistent with the neuroprotective effects of AMPK signaling [208,209].”
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101
Ruiz-Pozo, V. A., Tamayo-Trujillo, R., Cadena-Ullauri, S., Frias-Toral, E., Guevara-Ramírez, P., Paz-Cruz, E., Chapela, S., Montalván, M., Morales-López, T., Simancas-Racines, D., et al. (2023) · Nutrients · doi:10.3390/nu15163585 · Cited by 63
“Moreover, ghrelin can enhance several energy metabolic pathways like beta oxidation [133] and alleviate neuronal inflammation by reducing proinflammatory cytokines [134].”
BackgroundRusso, C., Valle, M. S., Russo, A., & Malaguarnera, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113432 · Cited by 40
Metadata
- Authors
- Reich, N., & Hölscher, C.
- Affiliations
- Lancaster University (GB)
- Henan University of Chinese Medicine (CN)
- Corresponding author
- Reich, Niklas
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2020-12-14
- Volume
- 14
- Pages
- 614828-614828
- ISSN
- 1662-453X (ISSN-L)
- PMC
- PMC7767977
- OpenAlex
- W3111850577
- Cited by
- 48
- References
- 476
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 7 · 2023: 9 · 2022: 13 · 2021: 6
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Lancaster EPrints (Lancaster University) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- acylated ghrelin, Alzheimer's disease, Parkinson's disease, neuroprotection, oxidative stress, mitochondrial dysfunction, autophagy, mitophagy, systemic inflammation, blood-brain barrier, dopamine depletion, neurogenesis, multi-target therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review